Welcome
Support Centre
23 May 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
A prospective randomised cross-over trial to examine the effect of auto variable positive airway pressure versus standard non-invasive positive pressure ventilation on stable chronic obstructive pulmonary disease-patients previously established on non-invasive ventilation
ISRCTN ISRCTN84977419
ClinicalTrials.gov identifier
Public title A prospective randomised cross-over trial to examine the effect of auto variable positive airway pressure versus standard non-invasive positive pressure ventilation on stable chronic obstructive pulmonary disease-patients previously established on non-invasive ventilation
Scientific title
Acronym N/A
Serial number at source P01033
Study hypothesis Auto Variable Positive Airway Pressure (AutoVPAP) is not as efficacious as Non-Invasive Positive Pressure Ventilation (NIPPV).
Lay summary
Ethics approval Approved by Huntingdon Research Ethics Committee (REC) on 5/09/2006 (reference number: 05/Q0104/118).
Study design Randomised crossover trial
Countries of recruitment United Kingdom
Disease/condition/study domain Chronic Obstructive Pulmonary Disease (COPD)
Participants - inclusion criteria 1. Chronic Obstructive Pulmonary Disease (COPD)
2. Forced Expiratory Volume in One second (FEV1) more than 50% predicted value
3. Smoking history more than 20 pack years
Participants - exclusion criteria 1. Aged over 80 years
2. No other significant lung disease
Anticipated start date 15/12/2005
Anticipated end date 15/12/2006
Status of trial Completed
Patient information material
Target number of participants 25
Interventions AutoVPAP versus NIPPV
Primary outcome measure(s) Nocturnal oxygenation
Secondary outcome measure(s) Quality of life
Sources of funding ResMed
Trial website
Publications 1. 2010 results in http://www.ncbi.nlm.nih.gov/pubmed/20546195
Contact name Dr  Nick  Oscroft
  Address Papworth Hospital
Papworth Everard
  City/town Cambridge
  Zip/Postcode CB3 8RE
  Country United Kingdom
  Tel +44 (0)1480 364495
  Fax +44 (0)1480 831450
  Email nick.oscroft@papworth.nhs.uk
Sponsor Papworth Hospital NHS Foundation Trust (UK)
  Address Papworth Hospital
Papworth Everard
  City/town Cambridge
  Zip/Postcode CB3 8RE
  Country United Kingdom
Date applied 03/08/2006
Last edited 14/12/2010
Date ISRCTN assigned 31/08/2006
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central